Consequences of Disclosing Clinical Trial Results: Evidence from the Food and Drug Administration Amendments Act
Author(s) -
Thomas Bourveau,
Vedran Čapkun,
Yin Wang
Publication year - 2020
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3533305
Subject(s) - food and drug administration , complaint , business , product (mathematics) , capital (architecture) , information asymmetry , drug , finance , medicine , pharmacology , law , political science , risk analysis (engineering) , geometry , mathematics , archaeology , history
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom